---
layout: post
title: DeNOVO Stratified
category: sports
---

Study Contact:  Grant Norte: 434-924-6184
IRB-HSR 16886, Clinic Visit Registration: 16886-Diduch

## Abreviated Inclusion Criteria

•	Age 18-55 years
•	Pre-treatment arthroscopic confirmation (at least one of the following) 
		One or two contained lesion(s) of the femoral condyle, trochlear groove, or patella (ICRS grade 3-4)
		OCD lesion(s) with healed bone base, non-sclerotic, no loss of bone > 6 mm from surrounding subchondral plate
•	Peripheral cartilage debridement to healthy cartilage that results in at least one lesion with an area of > 2 cm2 and ≤ 7.5 cm2
•	Lesion(s) to be treated must be contained by surrounding native cartilage > 70% of periphery
•	Ligaments in affected knee are stable
•	Ipsilateral knee compartment has intact menisci (or meniscectomized remnant > 5 mm rim)
•	Contralateral knee is asymptomatic, stable, and fully functional
•	Refractory to conservative treatment (HA/corticosteroid injection, arthroscopy/debridement/chondroplasty/loose body removal, and > 3 months from 	the start of either treatment
•	Moderate to Extreme pain indicated for any question of the KOOS-Pain Scale (P2-P9) 

## Abreviated Exclusion Criteria
•	More than two clinically relevant (≥ ICRS grade 3A) chondral lesion(s) of the index knee
•	Kissing lesions of the ipsilateral compartment if ≥ ICRS grade 3A on opposing articular surface
•	Prior tendon repair, meniscus repair, ligament repair, or distal re-alignment  in the index knee < 6 months prior to surgery
•	Prior microfracture or ACI in the index knee < 12 months prior to surgery
•	Prior cartilage repair with OATs, mosaicplasty, or osteochondral allograft
•	Prior total meniscectomy of either knee
•	Current procedure involves concomitant microfracture, ligament/tendon repair, distal re-alignment, complete meniscectomy, or repair of other 		chondral lesions in the affected knee with the exception of incidental loose body removal, debridement, synovectomy, retinacular release, and/or 	 partial meniscectomy with remaining rim > 5 mm wide
•	Severe patellofemoral or radiographically measured malalignment > 5° from hip, knee, and ankle mechanical axes
•	Secondary arthropathies (i.e. sickle cell, hemochromatosis, or autoimmune disease)
•	Knee OA, rheumatoid, or gout
•	Currently taking prescription pain medications (other than NSAIDs) for conditions unrelated to index knee
•	BMI > 35
•	Receiving workman’s compensation for knee injury

## Study Summary

•	Screening ≤ 60 days of surgery: Clinic visit (register to grant)
•	Baseline ≤ 60 days of surgery: Clinic visit (register to grant)
•	Surgery: Pre-authorize to insurance, Graft is covered by Company [MUST NOTIFY COMPANY]
•	6 weeks ± 10 days: Clinic visit (register to grant), Research MRI
•	6 months ± 30 days: Clinic visit (register to grant)
•	12 months ± 60 days: Clinic visit + X-rays (register to grant), Research MRI
•	18 months ± 60 days: Telephone call (register to grant)
•	2 years ± 60 days: Clinic visit + X-rays (register to grant), Research MRI
•	3 years ± 90 days: Telephone call (register to grant)
•	4 years ± 90 days: Telephone call (register to grant)
•	5 years ± 90 days: Telephone call (register to grant)

*Screening and baseline may be completed during the same visit

## Baseline visit: 
•	X-ray orders: PA fixed flexion, skyline, lateral 10° NWB, WB AP
•	MRI: done according to standard of care within 12 months of enrollment, not registered to grant

## 12 month visit: 
•	X-ray orders: PA fixed flexion, skyline, lateral 10° NWB, WB AP

## 24 month visit: 
•	X-ray orders: PA fixed flexion, skyline, lateral 10° NWB, WB AP

## Payment:
•	$50/follow up visit (8 total)
•	Complete vendor registration through UVA Procurement at: https://www.procurement.virginia.edu/pagevendorregistrationform
•	Contact Sarah Spangler (cc to Grant Norte) with patient name, MRN, DOS, study visit
